A combination approach, which included metabolic reprogramming and immunotherapy, led to complete tumor regression in 60% of study mice.
Michigan Medicine is renowned for groundbreaking clinical, basic science and medical educational research, with nearly 7,000 papers published annually by faculty and trainees. Here, Lab Notes highlights a selection of those articles in addition to ones covered as stories on the Michigan Health Lab blog.
By studying the roles of an inflammatory protein and antibodies in chronic rejection after lung transplantation, researchers discover possibilities for new treatments.
Researchers report the ability to improve safety and efficacy using a CRISPR-Cas9 variant known as miCas9.
National veterans’ study points to need for better support for people facing both conditions at once.
Basic science research explores the effects of impaired glycine metabolism in nonalcoholic fatty liver disease and how to potentially use glycine-based treatment to help people with NAFLD.